Product Presentation Pain - IOD - 1JN22-DIGITAL
Product Presentation Pain - IOD - 1JN22-DIGITAL
PAIN/ORTHO
PRODUCT
PORTFOLIO
FDA Approved
OUR OBJECTIVE
We pride ourselves in offering a full package of onboarding and
credentialing services, hands on training, and excellent customer
service to ensure your Point-of-Care Dispensing experience is best
in class.
• Improved Patient Care And Compliance
• Increased Revenue
• Large Medication Formulary And Competitive Pricing
• Inventory Management
• Simple Ordering And Quick Processing
• Practice Efficiency
WE CREDENTIAL DOCTORS
Our experienced team will guide you through the onboarding
process to ensure the practice collects the necessary documents to
dispense medications in your office. We understand the state laws
and requirements and are available for any questions the practice
has during their partnership with In-Office Dispensing Solutions.
The team then works on the behalf of the practice to license and
contract with 45+ Pharmacy Benefit Managers, and provides
detailed status updates and next steps throughout the process.
WEB-BASED SOFTWARE
A simple internet connection allows the practice to
manage, order, track and dispense medications.
POINT OF CARE DISPENSING
In-office physician dispensing of medications.
FORMULARY MANAGEMENT
We will support your team with selection and maintenance
of medications in the practice formulary.
TRAINING
In-office dispensing solutions offers training and ongoing
customer service to our partners.
NDC: 74157-007-60
DESCRIPTION
Diclofenac potassium is a benzeneacetic
acid derivative, designated chemically as
2-[(2,6-dichlorophenyl) amino] benzeneacetic acid,
INDICATIONS AND USAGE monopotassium salt. The molecular weight is 334.25.
• Treatment of primary dysmenorrhea Its molecular formula is C 14H 10C l2NKO 2.
(150mg or 6 pills/day) DOSAGE AND ADMINISTRATION
• Relief of mild to moderate pain For treatment of pain or primary dysmenorrhea
(150mg or 6 pills/day) the recommended dosage is 50 mg three times a
day. With experience, physicians may find that in
• Relief of the signs and symptoms of osteoarthritis some patients an initial dose of 100 mg of diclofenac
(200mg or 8 pills/day) potassium tablets, followed by 50-mg doses, will
• Relief of the signs and symptoms of rheumatoid provide better relief.
arthritis (200mg or 8 pills/day) For the relief of osteoarthritis the recommended
ADVERSE REACTIONS dosage is 100 to 150 mg/day in divided doses,
The following adverse reactions are discussed in 50 mg twice a day or three times a day.
greater detail in other sections of the labeling: For the relief of rheumatoid arthritis the
Cardiovascular Thrombotic Events (see WARNINGS) recommended dosage is 150 to 200 mg/day in divided
doses,
GI Bleeding, Ulceration and Perforation (see 50 mg three times a day or four times a day.
WARNINGS)
HOW SUPPLIED
Hepatotoxicity (see WARNINGS) Diclofenac potassium tablets, USP 25 mg are round,
white to off-white, biconvex coated tablets, debossed
Hypertension (see WARNINGS) ‘Λ’ on one side and plain other side are supplied as
Heart Failure and Edema (see WARNINGS) follows:
NDC 74157-007-60 in bottles of 60 tablets
Renal Toxicity and Hyperkalemia (see WARNINGS) Store at 20° to 25°C (68° to 77°F) [see USP Controlled
Anaphylactic Reactions (see WARNINGS) Room Temperature].
All trademarks are the property of their respective owners. Quantities are determined by prescriber.
SAMPLE FORMULARY PAIN/ORTHO
Topical Anesthetic
+
LIDOCAINE 5% OINTMENT 50G DOXEPIN 5% CREAM 45G
PHARMACEUTICALLY EQUIVALENT TO PHARMACEUTICALLY EQUIVALENT
XYLOCAINE® TO ZONALON®, PRUDOXIN®
Topical Steroid
DIFLORASONE 0.05% OINTMENT / HALCINONIDE 0.1% CREAM 30G HYDROCORTISONE BUTYRATE 0.1%
CREAM 60G LOTION 60ML / CREAM 60G
BIOEQUIVALENT TO HALOG®
BIOEQUIVALENT TO LOCOID®
BIOEQUIVALENT TO PSORCON®
Dermatitis/Pruritus
TACROLIMUS OINTMENT 0.03% OR 0.1% 100G SALICYLIC ACID/BENZOIC ACID 3-6% 30GM
BIOEQUIVALENT TO PROTOPIC® PHARMACEUTICALLY EQUIVALENT TO BENSAL HP®
Scar Care
or +
CALCIPOTRIENE 0.005%/ DIFLORASONE 0.05% OINTMENT / CALCIPOTRIENE 0.005% FOAM 60G
BETAMETHASONE DIP 0.064% CREAM 60G
PHARMACEUTICALLY EQUIVALENT TO
OINTMENT 60G AND 100G
PHARMACEUTICALLY EQUIVALENT TO SORILUX®
BIOEQUIVALENT TO TACLONEX® PSORCON®
Ulcer Prevention/Constipation
All trademarks are the property of their respective owners. Quantities are determined by prescriber.
www.IODRX.com
Phone 1.210.541.7844
Fax 1.210.610.5274